Drug Database
Back to search

Japan· JP-7219415A4030

イオヘキソール

A iohexol product containing イオヘキソール, registered in Japan by ＧＥヘルスケアファーマ, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

On Japan’s NHI price listATC V08AB02

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedイオヘキソールATCV08AB02REGISTER NO.JP-7219415A4030PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about イオヘキソールAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Iohexol is registered in 17 of 19 countries.

Countries holding a registration under ATC V08AB02 (iohexol), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 9 of them publish a price we can compare per daily dose
Search iohexol products by name

Iohexol · ATC V08AB02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
イオヘキソール
Manufacturer
ＧＥヘルスケアファーマ
Country
Japan (JP)
ATC code
V08AB02
ATC class
Iohexol
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

353 interactions on record for iohexol.

Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check iohexol against other medicinesHow interaction checks work

Iohexol · interactions on record

353 records

  • 286 severe
  • 54 moderate
  • 13 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • ThiethylperazinA04AB03severe
  • TriflupromazinA04AD06severe
  • DronabinolA04AD10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iohexol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iohexol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Accupaque, Iovision
  • Belgium · Omnipaque
  • Bulgaria · Kopaq, Контамедиа Йох
  • Cyprus · Omnipaque
  • Czechia · Omnipaque
  • Germany · Accupaque, Iovision
  • Estonia · Iohexol Imax, Omnipaque
  • Spain · Omnipaque
  • Finland · Omnipaque
  • France · Omnipaque
  • United Kingdom (Northern Ireland) · Iohexol Farmak Pharmaceuticals Uk, Iohexol Ge Healthcare
  • Greece · Omnipaque
  • Croatia · Omnipaque
  • Hungary · Iohexol Wogen, Omnipaque
  • Ireland · Omnipaque
  • Iceland · Omnipaque
  • Italy · Omnipaque
  • Lithuania · Iohexol Icg Farma, Iohexol Imax
  • Luxembourg · Omnipaque
  • Latvia · Iohexol Imax, Omnipaque
  • Malta · Omnipaque
  • Netherlands · Iohexol Adoh, Omnipaque
  • Norway · Omnipaque
  • Poland · Omnipaque
  • Portugal · Iohexol Imax, Omnipaque
  • Romania · Omnipaque
  • Sweden · Iovision, Omnipaque
  • Slovenia · Omnipaque
  • Slovakia · Omnipaque

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c24816e6-712d-4066-9aa1-15d9c28f52eb
GET /v1/drugs/c24816e6-712d-4066-9aa1-15d9c28f52eb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "５１．７７％１０ｍＬ１瓶",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "7219415A4030",
  "category": "注射薬",
  "price_yen": 640,
  "generic_name": "イオヘキソール",
  "product_name_jp": null,
  "therapeutic_class": "7219",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about iohexol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console